Top News

Pfenex Closes IPO

San Diego-based biotechnology company Pfenex said Tuesday that it has closed its initial public offering, where the company sold 8,333,333 shares of its stock at $6.00 per share. The company is now trading on the NYSE as PFNX. Pfenex closed down at $5.62 on Tuesday. The IPO was run by William Blair & Company, L.L.C. and JMP Securities LLC, along with Mizuho Securities USA Inc. Pfenex is a spinout of Dow Chemical, and is aiming its lead product at potential treatment of patients with retinal diseases.


 

Marketplace


 

 

Latest Headlines

Browse Issues

 
 

Keep up with all of the latest Southern California high tech news via email (it's free!)



or Cancel